# Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic Trioxide

> **NCT00850304** · PHASE2 · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 10 (actual)

## Conditions studied

- Leukemia, Myeloid, Acute

## Interventions

- **DRUG:** Cytosar
- **DRUG:** Arsenic trioxide

## Key facts

- **NCT ID:** NCT00850304
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2009-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00850304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00850304, "Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic Trioxide". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00850304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*